Covered recipient · General Payments record
RILEY F STAIR
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$896.94
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $338.64 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $85.98 | 5 |
| Abbott Laboratories | $59.00 | 3 |
| Lilly USA, LLC | $47.89 | 3 |
| ABBVIE INC. | $36.76 | 2 |
| PFIZER INC. | $36.56 | 2 |
| DEXCOM, INC. | $35.17 | 2 |
| Grifols USA, LLC | $21.87 | 1 |
| Acerta Pharma LLC | $15.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.43 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124852062 | CMS |
| Abbott Laboratories | $20.78 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124852064 | CMS |
| Abbott Laboratories | $18.79 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124852066 | CMS |
| ABBVIE INC. | $13.75 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152677 | CMS |
| ABBVIE INC. | $23.01 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152679 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.41 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105552662 | CMS |
| Dexcom, Inc. | $17.17 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153331055 | CMS |
| Dexcom, Inc. | $18.00 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153331057 | CMS |
| Grifols USA, LLC | $21.87 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124733099 | CMS |
| Lilly USA, LLC | $16.52 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135354468 | CMS |
| Lilly USA, LLC | $14.38 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135368184 | CMS |
| Lilly USA, LLC | $16.99 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135335312 | CMS |
| Novo Nordisk Inc | $13.68 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097412857 | CMS |
| Novo Nordisk Inc | $17.50 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097337620 | CMS |
| Novo Nordisk Inc | $18.20 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097661473 | CMS |
| Novo Nordisk Inc | $18.28 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097650862 | CMS |
| Novo Nordisk Inc | $18.32 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096938889 | CMS |
| PFIZER INC. | $17.20 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131775327 | CMS |
| PFIZER INC. | $19.36 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131424275 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.